Comparison between Beta Drugs IPO and Kaarya Facilities IPO.
Beta Drugs IPO is a SME Fixed Price IPO proposed to list at NSE SME while Kaarya Facilities IPO is a SME Fixed Price proposed to list at BSE SME.
| Beta Drugs IPO | Kaarya Facilities IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Pantomath Capital Advisors Pvt.Ltd. | First Overseas Capital Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Pantomath Stock Brokers Pvt.Ltd. | K.K.Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Beta Drugs IPO is up to ₹18.41 Cr whereas the issue size of the Kaarya Facilities IPO is up to ₹6.07 Cr. The final issue price of Beta Drugs IPO is ₹85.00 per share and of Kaarya Facilities IPO is ₹40.00 per share.
| Beta Drugs IPO | Kaarya Facilities IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹85.00 per share | ₹40.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 3000 shares |
| Fresh Issue Size | 21,66,400 shares | 15,18,000 shares |
| Fresh Issue Size (Amount) | up to ₹18.41 Cr | up to ₹6.07 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 21,66,400 shares | 15,18,000 shares |
| Issue Size Total (Amount) | up to ₹18.41 Cr | up to ₹6.07 Cr |
Beta Drugs IPO opens on Sep 29, 2017, while Kaarya Facilities IPO opens on Oct 12, 2017. The closing date of Beta Drugs IPO and Kaarya Facilities IPO is Oct 04, 2017, and Oct 17, 2017, respectively.
| Beta Drugs IPO | Kaarya Facilities IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 29, 2017 | Oct 12, 2017 |
| Issue Close | Oct 04, 2017 | Oct 17, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Oct 12, 2017 | Oct 27, 2017 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Beta Drugs IPO P/E ratio is , as compared to Kaarya Facilities IPO P/E ratio of .
| Beta Drugs IPO | Kaarya Facilities IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹73.52 Cr. | ₹18.70 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Beta Drugs IPO Retail Individual Investors (RII) are offered 10,83,200 shares while in Kaarya Facilities IPO retail investors are offered 10,83,200 shares. Qualified Institutional Buyers (QIB) are offered in Beta Drugs IPO and in Kaarya Facilities IPO.
| Beta Drugs IPO | Kaarya Facilities IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 1,29,600 shares | 81,000 shares |
| QIB | ||
| NII | 10,83,200 shares | 7,59,000 shares |
| RII | 10,83,200 shares | 7,59,000 shares |
| Employee | ||
| Others | ||
| Total | 21,66,400 shares | 15,18,000 shares |
Beta Drugs IPO subscribed 18.97x in total, whereas Kaarya Facilities IPO subscribed 18.90x.
| Beta Drugs IPO | Kaarya Facilities IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 29.93x | 14.97x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 8.00x | 22.83x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 18.97x | 18.90x |
